Axonics
Axonics is a company. It is a public company in Irvine, the United States. It was founded in 2013 and its current CEO is Raymond W. Cohen. It is part of the Health Care sector, specifically in the Health Care Equipment & Supplies industry.
Key facts
- city: Irvine
- state: CA
- country: United States
- employees: 517 people
- revenues: 194.3M $
- company type: public
- sector: Health Care
- industry: Health Care Equipment & Supplies
- foundation year: 2013
- CEO: Raymond W. Cohen
- ESG score: Try Pro to see estimate
Extract data
Download datasets about Axonics:
Dataset of stocks from Axonics:
Axonics is one of the companies in the United States, companies in Health Care Equipment & Supplies, companies in Health Care, companies in Irvine and 3,456,808 companies in our database.
Talking Points
- Axonics® Therapy | Get Your Bladder Back
- Axonics® System is an FDA-approved, clinically proven Sacral Neuromodulation solution for the treatment of urinary and bowel dysfunction.
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.